FI20075059A0 - Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus - Google Patents

Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus

Info

Publication number
FI20075059A0
FI20075059A0 FI20075059A FI20075059A FI20075059A0 FI 20075059 A0 FI20075059 A0 FI 20075059A0 FI 20075059 A FI20075059 A FI 20075059A FI 20075059 A FI20075059 A FI 20075059A FI 20075059 A0 FI20075059 A0 FI 20075059A0
Authority
FI
Finland
Prior art keywords
allergen
ige
immunocomplex
hypoallergenic
genes
Prior art date
Application number
FI20075059A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Sirpa Jylhae
Merja Niemi
Juha Rouvinen
Marja-Leena Laukkanen
Kristiina Takkinen
Hans Soederlund
Soili Maekinen-Kiljunen
Tari Haahtela
Original Assignee
Valtion Teknillinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen filed Critical Valtion Teknillinen
Priority to FI20075059A priority Critical patent/FI20075059A0/fi
Publication of FI20075059A0 publication Critical patent/FI20075059A0/fi
Priority to SI200831457T priority patent/SI2114996T1/sl
Priority to HUE08709295A priority patent/HUE026979T2/en
Priority to PT87092953T priority patent/PT2114996E/pt
Priority to PL08709295T priority patent/PL2114996T3/pl
Priority to JP2009546784A priority patent/JP5444001B2/ja
Priority to CA002676843A priority patent/CA2676843A1/en
Priority to AU2008211807A priority patent/AU2008211807B2/en
Priority to JP2009546785A priority patent/JP2010516747A/ja
Priority to NZ577858A priority patent/NZ577858A/en
Priority to DK08709295.3T priority patent/DK2114996T3/en
Priority to US12/523,140 priority patent/US20100311604A1/en
Priority to CA2676838A priority patent/CA2676838C/en
Priority to AU2008211806A priority patent/AU2008211806B2/en
Priority to NZ578068A priority patent/NZ578068A/xx
Priority to EP08709295.3A priority patent/EP2114996B8/de
Priority to PCT/FI2008/050026 priority patent/WO2008092992A1/en
Priority to ES08709295.3T priority patent/ES2544580T3/es
Priority to EP08709296.1A priority patent/EP2115139B8/de
Priority to PCT/FI2008/050027 priority patent/WO2008092993A1/en
Priority to US12/523,151 priority patent/US9261511B2/en
Priority to HRP20150775TT priority patent/HRP20150775T1/hr
Priority to CY20151100671T priority patent/CY1116564T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20075059A 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus FI20075059A0 (fi)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FI20075059A FI20075059A0 (fi) 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus
US12/523,151 US9261511B2 (en) 2007-01-29 2008-01-29 Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens
DK08709295.3T DK2114996T3 (en) 2007-01-29 2008-01-29 A process for the preparation of hypo allergens
CA2676838A CA2676838C (en) 2007-01-29 2008-01-29 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
PT87092953T PT2114996E (pt) 2007-01-29 2008-01-29 Anticorpos monoclonais ige que se ligam a alergénios e método para preparação de hipoalergénios
PL08709295T PL2114996T3 (pl) 2007-01-29 2008-01-29 Sposób otrzymywania hipoalergenów
JP2009546784A JP5444001B2 (ja) 2007-01-29 2008-01-29 アレルゲン結合性ＩｇＥモノクローナル抗体および低アレルギー性物質の製造方法
CA002676843A CA2676843A1 (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents
AU2008211807A AU2008211807B2 (en) 2007-01-29 2008-01-29 Method for producing novel IgE based reagents
JP2009546785A JP2010516747A (ja) 2007-01-29 2008-01-29 ＩｇＥを主成分とする新規試薬の製造方法
NZ577858A NZ577858A (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents
SI200831457T SI2114996T1 (sl) 2007-01-29 2008-01-29 Metoda za pripravo hipoalergenov
US12/523,140 US20100311604A1 (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents
HUE08709295A HUE026979T2 (en) 2007-01-29 2008-01-29 A method for producing hypoallergenics
AU2008211806A AU2008211806B2 (en) 2007-01-29 2008-01-29 Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens
NZ578068A NZ578068A (en) 2007-01-29 2008-01-29 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
EP08709295.3A EP2114996B8 (de) 2007-01-29 2008-01-29 Verfahren zur herstellung von hypoallergenen
PCT/FI2008/050026 WO2008092992A1 (en) 2007-01-29 2008-01-29 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
ES08709295.3T ES2544580T3 (es) 2007-01-29 2008-01-29 Método para preparar hipoalérgenos
EP08709296.1A EP2115139B8 (de) 2007-01-29 2008-01-29 Verfahren zur herstellung neuer reagentien auf ige-basis
PCT/FI2008/050027 WO2008092993A1 (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents
HRP20150775TT HRP20150775T1 (en) 2007-01-29 2015-07-14 Method for preparing hypoallergens
CY20151100671T CY1116564T1 (el) 2007-01-29 2015-07-29 Μεθοδος για παρασκευη υποαλλεργιογονων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075059A FI20075059A0 (fi) 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus

Publications (1)

Publication Number Publication Date
FI20075059A0 true FI20075059A0 (fi) 2007-01-29

Family

ID=37745752

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075059A FI20075059A0 (fi) 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus

Country Status (15)

Country Link
US (1) US9261511B2 (de)
EP (1) EP2114996B8 (de)
JP (1) JP5444001B2 (de)
AU (1) AU2008211806B2 (de)
CA (1) CA2676838C (de)
DK (1) DK2114996T3 (de)
ES (1) ES2544580T3 (de)
FI (1) FI20075059A0 (de)
HR (1) HRP20150775T1 (de)
HU (1) HUE026979T2 (de)
NZ (1) NZ578068A (de)
PL (1) PL2114996T3 (de)
PT (1) PT2114996E (de)
SI (1) SI2114996T1 (de)
WO (1) WO2008092992A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
EP3424943A4 (de) * 2016-02-29 2019-08-14 Kyoto University Peptid
MY191649A (en) 2016-03-04 2022-07-05 Jn Biosciences Llc Antibodies to tigit
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
CN110531060A (zh) * 2019-09-03 2019-12-03 东北农业大学 一种利用靶向定位结合酶水解降低β-乳球蛋白致敏性的方法
CA3172390A1 (en) * 2020-02-19 2021-08-26 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
BR112022024221A2 (pt) 2020-06-02 2022-12-20 Arcus Biosciences Inc Anticorpos para tigit

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4949778A (en) 1987-12-16 1990-08-21 Kawasaki Steel Corporation Immersion nozzle for continuous casting
JP3475221B2 (ja) * 1994-09-05 2003-12-08 明治乳業株式会社 免疫原性が低下された変異体タンパク質
US6037454A (en) * 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
EP2236611A1 (de) 2000-04-28 2010-10-06 Novozymes A/S Variante eines lipolytischen Enzyms
US20030175312A1 (en) 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
FI112501B (fi) 2001-05-18 2003-12-15 Valtion Teknillinen Heveiiniä sitovat monoklonaaliset vasta-aineet
US20030180296A1 (en) 2001-12-20 2003-09-25 Theodora Salcedo Antibodies that immunospecifically bind to trail receptors
PL212139B1 (pl) 2002-05-16 2012-08-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja zawierająca dwa lub więcej wariantów zrekombinowanych zmutowanych alergenów, zastosowanie takiej kompozycji, kompozycja farmaceutyczna zawierająca zrekombinowany alergen lub wymienioną kompozycję, zastosowanie zrekombinowanego alergenu, kompozycji lub kompozycji farmaceutycznej, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sposób przygotowania biblioteki zrekombinowanego alergenu, sekwencja DNA kodująca zrekombinowany alergen, wektor ekspresyjny obejmujący wymienione DNA, komórka gospodarza zawierająca taki wektor ekspresyjny, sposób produkcji zrekombinowanego mutanta alergenu, oraz oznaczenie diagnostyczne do oceny odpowiedniości, bezpieczeństwa lub wyniku terapii
DE60324794D1 (de) * 2003-09-04 2009-01-02 Biomay Ag Hypoallergene Polypeptide basierend auf aus Fisch gewonnenem Parvalbumin
WO2006026994A1 (en) * 2004-09-09 2006-03-16 Alk-Abelló A/S Crystal structure of house dust mite allergen der p 1
WO2006125201A2 (en) 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
FI20115374A0 (fi) * 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit

Also Published As

Publication number Publication date
EP2114996B8 (de) 2015-06-10
CA2676838C (en) 2015-06-16
PT2114996E (pt) 2015-09-21
NZ578068A (en) 2012-03-30
CA2676838A1 (en) 2008-08-07
AU2008211806B2 (en) 2013-02-14
EP2114996A1 (de) 2009-11-11
DK2114996T3 (en) 2015-08-03
HUE026979T2 (en) 2016-07-28
AU2008211806A1 (en) 2008-08-07
US20100086552A1 (en) 2010-04-08
WO2008092992A1 (en) 2008-08-07
SI2114996T1 (sl) 2015-10-30
ES2544580T3 (es) 2015-09-01
JP2010521138A (ja) 2010-06-24
EP2114996A4 (de) 2012-05-09
PL2114996T3 (pl) 2015-10-30
JP5444001B2 (ja) 2014-03-19
HRP20150775T1 (en) 2015-09-11
EP2114996B1 (de) 2015-05-06
US9261511B2 (en) 2016-02-16

Similar Documents

Publication Publication Date Title
CY2020021I2 (el) Αντισωματα και ανοσοσυζευγματα αντι-cd79b και μεθοδοι χρησης
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
CU23869B1 (es) Anticuerpos anti-esclerostina y proteínas funcionales
CY2017043I2 (el) Anti-pd-l1 αντισωματα και χρηση αυτων για την ενισχυση της λειτουργιας τ-κυτταρων
FI20075059A0 (fi) Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus
SMT201600288B (it) SPECIFICI ANTICORPI IgE
BRPI0809677A2 (pt) Anticorpos anti-ige
BRPI0822447A2 (pt) Anticorpo monoclonal e método do mesmo
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0819909A2 (pt) anticorpos antimesotelina e usos dos mesmos
BRPI0821110A2 (pt) Anticorpo anti nr-10 e uso do mesmo
BRPI0913656A2 (pt) anticorpos anti-cdh3 marcados com marcador radioisótopo e usos dos mesmos
BRPI0820298A2 (pt) anticorpos anti-vegf composições e métodos
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
CR10466A (es) Anticuerpos e inmunoconjugados y sus usos
BRPI0914943A2 (pt) anticorpos de il-6 e sua utilizaÇço
BRPI0917888A2 (pt) Formulação de anticorpo líquida estável
NO20076607L (no) TWEAK - bindende antistoff
DK1964852T3 (da) Anti-ilt7-antistof
ATE513855T1 (de) Antikörper gegen il-13-rezeptor-alpha-1 und verwendungen dafür
NO20082454L (no) Anti-alfa2 integrin antistoffer og deres anvendelser
NO20071069L (no) Anti-CD154-antistoff
BRPI0813514A2 (pt) anticorpos anti-cd79b humanizados e imunoconjugados e métodos de uso
FR2888850B1 (fr) Nouveaux anticorps anti-igf-ir et leurs applications
DK2252633T3 (da) Anti-TrkA antistoffer og derivater deraf

Legal Events

Date Code Title Description
FD Application lapsed